HKD 3.58
(-0.56%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -78.69 Million USD | 10.88% |
2022 | -88.29 Million USD | 58.56% |
2021 | -213.07 Million USD | -386.77% |
2020 | -43.77 Million USD | -167.21% |
2019 | -16.38 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 FY | -78.69 Million USD | 10.88% |
2023 Q1 | - HKD | 0.0% |
2023 Q2 | - HKD | 0.0% |
2023 Q3 | - HKD | 0.0% |
2022 FY | -88.29 Million USD | 58.56% |
2022 Q4 | - HKD | 0.0% |
2022 Q3 | - HKD | 0.0% |
2021 Q3 | -15.64 Million USD | 0.0% |
2021 Q4 | -165 Million USD | -954.99% |
2021 FY | -213.07 Million USD | -386.77% |
2020 Q4 | -11.82 Million USD | 0.0% |
2020 FY | -43.77 Million USD | -167.21% |
2019 FY | -16.38 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 211.026% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 556.18% |